6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Altamira Therapeutics Ltd.
Filed: September 11, 2020
Period of Report: September 11, 2020
Accession Number: 0001213900-20-026285

View Document ↗ View on SEC.gov ↗